Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMDP) Gross Margin (2016 - 2025)

Historic Gross Margin for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to 87.69%.

  • LifeMD's Gross Margin fell 29000.0% to 87.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 86.65%, marking a year-over-year decrease of 29900.0%. This contributed to the annual value of 88.48% for FY2024, which is 8700.0% up from last year.
  • As of Q3 2025, LifeMD's Gross Margin stood at 87.69%, which was down 29000.0% from 88.14% recorded in Q2 2025.
  • In the past 5 years, LifeMD's Gross Margin registered a high of 90.59% during Q3 2024, and its lowest value of 79.57% during Q3 2021.
  • In the last 5 years, LifeMD's Gross Margin had a median value of 86.52% in 2025 and averaged 85.65%.
  • Over the last 5 years, LifeMD's Gross Margin had its largest YoY gain of 134300bps in 2021, and its largest YoY loss of -52000bps in 2021.
  • Over the past 5 years, LifeMD's Gross Margin (Quarter) stood at 79.69% in 2021, then increased by 7bps to 85.53% in 2022, then rose by 3bps to 88.06% in 2023, then fell by -4bps to 84.15% in 2024, then grew by 4bps to 87.69% in 2025.
  • Its Gross Margin was 87.69% in Q3 2025, compared to 88.14% in Q2 2025 and 86.52% in Q1 2025.